Stereotactic Radiosurgery (SRS) with Immune Checkpoint Inhibitor Therapy (ICI) for Patients with Brain Metastasis (BM): The Impact of Timing and Sequencing

Rupesh Kotecha

Stereotactic Radiosurgery (SRS) with Immune Checkpoint Inhibitor Therapy (ICI) for Patients with Brain Metastasis (BM): The Impact of Timing and Sequencing

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	International Journal of Radiation Oncology, Biology, Physics
Volume	102
State	Published - Nov 1 2018

Access to Document

ViewcontentFinal published version, 20.4 KBLicense: Unspecified

Cite this

@article{78c26542c01a4cbab48cda969279e7c1,

title = "Stereotactic Radiosurgery (SRS) with Immune Checkpoint Inhibitor Therapy (ICI) for Patients with Brain Metastasis (BM): The Impact of Timing and Sequencing",

author = "Rupesh Kotecha",

note = "Int J Radiat Oncol Biol Phys (2018) 102(3 Supplement):e345-e346",

year = "2018",

month = nov,

day = "1",

language = "American English",

volume = "102",

journal = "International Journal of Radiation Oncology, Biology, Physics",

}

TY - JOUR

T1 - Stereotactic Radiosurgery (SRS) with Immune Checkpoint Inhibitor Therapy (ICI) for Patients with Brain Metastasis (BM): The Impact of Timing and Sequencing

AU - Kotecha, Rupesh

N1 - Int J Radiat Oncol Biol Phys (2018) 102(3 Supplement):e345-e346

PY - 2018/11/1

Y1 - 2018/11/1

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/3027

M3 - Article

VL - 102

JO - International Journal of Radiation Oncology, Biology, Physics

JF - International Journal of Radiation Oncology, Biology, Physics

ER -

Stereotactic Radiosurgery (SRS) with Immune Checkpoint Inhibitor Therapy (ICI) for Patients with Brain Metastasis (BM): The Impact of Timing and Sequencing

Access to Document

Other files and links

Cite this